Treatment of Myotonia – Lamotrigine Versus Namuscla
Condition(s):Non-Dystrophic MyotoniaLast Updated:December 6, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Non-Dystrophic MyotoniaLast Updated:December 6, 2022Recruiting
Condition(s):Non-Dystrophic MyotoniaLast Updated:February 9, 2024Not yet recruiting
Condition(s):Congenital MyotoniaLast Updated:May 14, 2015Completed
Condition(s):Non-Dystrophic MyotoniaLast Updated:November 2, 2022Recruiting
Condition(s):Non Dystrophic MyotoniaLast Updated:January 26, 2016Completed
Condition(s):Non-Dystrophic Myotonia; Myotonia CongenitaLast Updated:March 30, 2023Completed
Condition(s):Myotonia; Non-Dystrophic MyotoniaLast Updated:August 23, 2013Completed
Condition(s):Non-dystrophic Myotonias; Paramyotonia Congenita; Myotonia CongenitaLast Updated:January 13, 2015Completed
Condition(s):Nondystrophic Myotonias; Myotonia Congenita; Myotonic DisordersLast Updated:March 6, 2013Completed
Condition(s):Myotonia Congenita; Paramyotonia Congenita; Myotonic Dystrophy 1Last Updated:March 5, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.